Hjem › Myeloproliferative neoplasmer › Illinois › Springfield
Myeloproliferative neoplasmer kliniske forsøg i Springfield, IL
3 studier for Myeloproliferative neoplasmer søger deltagere på steder i og omkring Springfield (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Project: Every Child for Younger Patients With Cancer
RekruttererObservationsstudie
- Saint John's Hospital, Springfield
- Southern Illinois University School of Medicine, Springfield
Myeloproliferative neoplasmer forsøg i andre byer
- Houston, TX16 studier
- New York City, NY15 studier
- Boston, MA14 studier
- Milwaukee, WI10 studier
- Miami, FL10 studier
- Chicago, IL9 studier
- Durham, NC9 studier
- Baldwin Park, CA9 studier
- Seattle, WA9 studier
- Salt Lake City, UT8 studier
- Cleveland, OH8 studier
- Birmingham, AL8 studier
Andre studier i Springfield
- Ikke-småcellet lungecancer13 studier
- Lungecancer12 studier
- Colorektal kræft9 studier
- Akut myeloid leukæmi8 studier
- Brystkræft8 studier
- Pladecellekræft i hoved og hals6 studier
- Nyrekancer (renocellulært karcinom)6 studier
- Prostatakræft6 studier
- Kræft (alle typer)6 studier
- Blærecancer6 studier
- Bugspytkirtelkræft5 studier
- Melanom5 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.